Standard Biotools (LAB) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -260.86% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | -189.36% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 73.12% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 188.37% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 576.28% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 103.25% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 130.07% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -39.60% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -42.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.99% |
| Mar 31, 2026 | 1,019.85% |
| Dec 31, 2025 | 79.91% |
| Sep 30, 2025 | 50.65% |
| Jun 30, 2025 | 140.48% |
| Mar 31, 2025 | -106.66% |
| Dec 31, 2024 | -52.06% |
| Sep 30, 2024 | 6.00% |
| Jun 30, 2024 | -159.75% |
| Mar 31, 2024 | 634.53% |
| Dec 31, 2023 | -235.52% |
| Sep 30, 2023 | -350.30% |
| Jun 30, 2023 | -35.81% |
| Mar 31, 2023 | 1,885.84% |
| Sep 30, 2022 | 64.59% |
| Jun 30, 2022 | 218.27% |
| Mar 31, 2022 | 108.58% |
| Sep 30, 2021 | -235.03% |
| Jun 30, 2021 | -581.95% |
| Mar 31, 2021 | -248.87% |